GB9812662D0 - Therapeutic use - Google Patents

Therapeutic use

Info

Publication number
GB9812662D0
GB9812662D0 GBGB9812662.6A GB9812662A GB9812662D0 GB 9812662 D0 GB9812662 D0 GB 9812662D0 GB 9812662 A GB9812662 A GB 9812662A GB 9812662 D0 GB9812662 D0 GB 9812662D0
Authority
GB
United Kingdom
Prior art keywords
therapeutic use
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9812662.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organon Pharma UK Ltd
Original Assignee
Merck Sharp and Dohme Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp and Dohme Ltd filed Critical Merck Sharp and Dohme Ltd
Priority to GBGB9812662.6A priority Critical patent/GB9812662D0/en
Publication of GB9812662D0 publication Critical patent/GB9812662D0/en
Priority to AU42795/99A priority patent/AU4279599A/en
Priority to EP99955426A priority patent/EP1119358A1/en
Priority to CA002334606A priority patent/CA2334606A1/en
Priority to PCT/GB1999/001818 priority patent/WO1999064009A1/en
Ceased legal-status Critical Current

Links

GBGB9812662.6A 1998-06-11 1998-06-11 Therapeutic use Ceased GB9812662D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GBGB9812662.6A GB9812662D0 (en) 1998-06-11 1998-06-11 Therapeutic use
AU42795/99A AU4279599A (en) 1998-06-11 1999-06-08 Use of an nk-1 receptor antagonist for treating cognitive disorders
EP99955426A EP1119358A1 (en) 1998-06-11 1999-06-08 Use of an nk-1 receptor antagonist for treating cognitive disorders
CA002334606A CA2334606A1 (en) 1998-06-11 1999-06-08 Use of an nk-1 receptor antagonist for treating cognitive disorders
PCT/GB1999/001818 WO1999064009A1 (en) 1998-06-11 1999-06-08 Use of an nk-1 receptor antagonist for treating cognitive disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9812662.6A GB9812662D0 (en) 1998-06-11 1998-06-11 Therapeutic use

Publications (1)

Publication Number Publication Date
GB9812662D0 true GB9812662D0 (en) 1998-08-12

Family

ID=10833616

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9812662.6A Ceased GB9812662D0 (en) 1998-06-11 1998-06-11 Therapeutic use

Country Status (5)

Country Link
EP (1) EP1119358A1 (en)
AU (1) AU4279599A (en)
CA (1) CA2334606A1 (en)
GB (1) GB9812662D0 (en)
WO (1) WO1999064009A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ514600A0 (en) * 2000-01-18 2000-02-10 James Cook University Brain injury treatment
GB0020721D0 (en) * 2000-08-22 2000-10-11 Merck Sharp & Dohme Therapeutic agents
WO2004017977A2 (en) 2002-08-23 2004-03-04 Eli Lilly And Company 2- (phenoxymethyl)- and 2- (phenylthiomethyl)-morpholine derivatives for use as selective norepinephrine reuptake inhibitors
GB0219687D0 (en) 2002-08-23 2002-10-02 Lilly Co Eli Benzyl morpholine derivatives

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1082959A1 (en) * 1991-09-20 2001-03-14 Glaxo Group Limited NK1 Antagonists for the treatment of depression
US5719147A (en) * 1992-06-29 1998-02-17 Merck & Co., Inc. Morpholine and thiomorpholine tachykinin receptor antagonists
PL181214B1 (en) * 1993-12-29 2001-06-29 Merck Sharp & Dohme Derivatives o substituted morpholine and their application as pharmaceutic agents
WO1996024353A1 (en) * 1995-02-10 1996-08-15 Eli Lilly And Company Methods of treating or preventing psychiatric disorders
GB9505491D0 (en) * 1995-03-18 1995-05-03 Merck Sharp & Dohme Therapeutic agents
GB9505692D0 (en) * 1995-03-21 1995-05-10 Glaxo Group Ltd Chemical compounds
EA001574B1 (en) * 1996-06-21 2001-06-25 Мерк Шарп Энд Домэ Лимитед Spiro-piperidine derivatives and their use as therapeutic agents.
WO1998013369A1 (en) * 1996-09-25 1998-04-02 Merck Sharp & Dohme Limited Spiro-azacyclic derivatives, their preparation and their use as tachykinin antagonists
GB9711114D0 (en) * 1997-05-29 1997-07-23 Merck Sharp & Dohme Therapeutic agents
WO1999007375A1 (en) * 1997-08-04 1999-02-18 Merck Sharp & Dohme Limited Use of nk-1 receptor antagonists for treating aggressive behaviour disorders
TW426667B (en) * 1997-11-19 2001-03-21 Pfizer Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance P antagonists

Also Published As

Publication number Publication date
WO1999064009A1 (en) 1999-12-16
AU4279599A (en) 1999-12-30
EP1119358A1 (en) 2001-08-01
CA2334606A1 (en) 1999-12-16

Similar Documents

Publication Publication Date Title
GB9820113D0 (en) Therapeutic agents
GB9816263D0 (en) Therapeutic agents
GB9806102D0 (en) Therapeutic agents
GB9804885D0 (en) Therapeutic combination
GB9808663D0 (en) Therapeutic agents
GB9801234D0 (en) Therapeutic agents
GB9813576D0 (en) Therapeutic agents
GB9813006D0 (en) Therapeutic agents
GB9801210D0 (en) Therapeutic agents
AP9901436A0 (en) Therapeutic agents
GB9801397D0 (en) Therapeutic agents
GB9801202D0 (en) Therapeutic agents
GB9810092D0 (en) Therapeutic agents
GB9811879D0 (en) Therapeutic agents
GB9819484D0 (en) Therapeutic agents
GB9816897D0 (en) Therapeutic use
GB9812662D0 (en) Therapeutic use
GB9810920D0 (en) Therapeutic use
GB9815317D0 (en) Therapeutic agents
GB9805716D0 (en) Therapeutic agents
GB9817838D0 (en) Therapeutic agents
GB9821179D0 (en) Therapeutic use
GB9811624D0 (en) Therapeutic use
GB9816723D0 (en) Therapeutic agents
GB9812664D0 (en) Therapeutic use

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)